Cargando…
Network pharmacology mechanism of Scutellarin to inhibit RGC pyroptosis in diabetic retinopathy
To investigate the effect of scutellarin (SCU) in diabetic retinopathy (DR) and explore the associated molecular network mechanism. The animal model of DR was established from diabetic mellitus (DM) rats by intraperitoneally injected streptozotocin (STZ) at dosage 55 mg/kg. Meanwhile, SCU was intrap...
Autores principales: | Li, Na, Guo, Xi-Liang, Xu, Min, Chen, Ji-Lin, Wang, Yu-Fei, Jie-Sun, Xiao, Yu-Gao, Gao, An-Shun, Zhang, Lan-Chun, Liu, Xue-Zheng, Wang, Ting-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119430/ https://www.ncbi.nlm.nih.gov/pubmed/37081038 http://dx.doi.org/10.1038/s41598-023-33665-3 |
Ejemplares similares
-
Scutellarin inhibits caspase-11 activation and pyroptosis in macrophages via regulating PKA signaling
por: Ye, Jiezhou, et al.
Publicado: (2021) -
Scutellarin Loaded on Ultradeformable Nanoliposome Scutellarin EDTMP (S-UNL-E) Promotes Osteogenesis in Osteoporotic Rats
por: Teng, Minhua, et al.
Publicado: (2022) -
Loss of Response Gene to Complement 32 (RGC-32) in Diabetic Mouse Retina Is Involved in Retinopathy Development
por: Liao, Wen-Ling, et al.
Publicado: (2018) -
Pharmacological basis for application of scutellarin in Alzheimer's disease: Antioxidation and antiapoptosis
por: Hu, Xinyu, et al.
Publicado: (2018) -
Anti-colorectal cancer effects of scutellarin revealed by genomic and proteomic analysis
por: Xiong, Liu-Lin, et al.
Publicado: (2020)